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An immunoinformatics study was conducted to determine the highly conserved antigenic epitope regions of
hemagglutinin (HA) and neuraminidase (NA) genes in the humoral immunity and CD4+ and CD8+ T cellular
immunity between 2009 pandemic H1N1 (pH1N1) and seasonal H1N1 (sH1N1) viruses. It was found that in sH1N1
viruses, 29 epitope regions of HA genes and 8 epitope regions of NA genes which had been experimentally
identified, were highly conserved (97.1-100.0%) in the corresponding genes and predictive epitopes of the pH1N1
viruses. The results suggested that highly conserved antigenic epitope regions might act as the basis of common
antigenic vaccines against pH1N1 and sH1N1 viruses.
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On April 15 2009, a novel pandemic influenza A
(pH1N1) virus was identified from specimens obtained
from influenza patients in the United States, subse-
quently, large numbers of confirmed cases of human
pH1N1 have been identified worldwide [1]. The pH1N1
virus contains a combination of gene segments that has
not previously been reported in swine or human influen-
za viruses either in the USA or elsewhere [2]. Viruses
with a NA gene segment were originally derived from a
wholly avian influenza virus, which entered the Eurasian
swine population in 1979. It continued to circulate
throughout Eurasia [3], however, it had not been pre-
viously reported outside this region. The HA gene seg-
ment was part of the classical swine lineage with the
virus infecting pigs around 1918 and subsequently circu-
lated in classical swine viruses and triple reassortant
swine viruses [4].* Correspondence: pphuang1@163.com
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reproduction in any medium, provided the orInfluenza pandemics occur when human have no im-
munity against a particular influenza virus, in this case,
containing both HA and NA genes that evolve to be ef-
ficiently transmitted from human-to-human. The ge-
nomes of the last three pandemic influenza viruses
(1918 H1N1, 1957 H2N2 and 1968 H3N2) all originated
either wholly or partly from non-human reservoirs, with
the HA genes of all pandemic viruses ultimately origi-
nating from avian influenza viruses [2]. The pH1N1
virus induced most neutralizing antibodies, which were
broadly cross-reactive against epitopes in the hemag-
glutinin (HA) stalk and head domain of multiple influ-
enza strains, including the seasonal H1N1 virus (sH1N1)
[5]. Based on the above observations, it was postulated
that the plasmablasts that produced these broadly neu-
tralizing antibodies were predominantly derived from
activated memory B cells specific for epitopes conserved
in some influenza strains. As immunity against influenza
viruses involved not only B cell activation, but also T cell
recognition and presentation, the T cell subgroups
undoubtedly play an important role. By performing
large-scale major histocompatibility complex (MHC) II
analyses on HA proteins, the degree of T-cell cross-
reactivity between sH1N1 from 1968 to 2009 andLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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reactivity was estimated at 52% between sH1N1 and
pH1N1 [6]. From biological studies using peripheral
blood mononuclear cell (PBMC) from human donors
not previously exposed to the pandemic virus, pre-
existing CD4+ T cells can elicit cross-reactive effector
responses against the pandemic H1N1 virus. Computa-
tional tools were 80–90% accurate in predicting CD4+ T
cell epitopes and their HLA-DRB1 -dependent response
profiles in donors selected at random for human
leukocyte antigen (HLA) haplotype [7]. HLA, also
known as human MHC, is classically divided MHC I, II,
III with human immunity against influenza involving
MHC I and MHC II alleles in influenza. In this study,
the highly conserved antigenic epitopes sequences and
the locations of HA and NA proteins, including B-cell
epitopes, MHC I and MHC II epitopes between pH1N1
and sH1N1 viruses, based on immunoinformatics, were
analyzed. There were compared with epitopes in the
Immune Epitope Database (IEDB) which contains ex-
perimentally identified epitopes in sH1N1 HA proteins,
which may be helpful in design of common antigens of
pH1N1 influenza and sH1N1 viruses.
Methods
Gene sequences sequenced and downloaded
The HA and NA gene sequences of nine pH1N1 viruses
isolated from Guangdong, China, were sequenced
(GenBank accession numbers GU471691–GU471695 and
GU562466– GU562469 for NA and CY120915–CY120924
and CY120952 for HA), and the global corresponding
genes (59 isolates) were obtained from GenBank. The 1495
HA and 2005 NA gene sequences of sH1N1 influenza
isolated between 1998 and 2008 were downloaded from
GenBank.
Prediction of B-cell epitopes, MHC I Epitopes and MHC II
Epitopes
The B-cell epitopes containing at least 10 amino acids were
predicted by ABCpred with a threshold values of 0.51 [8].
The MHC I molecules predicted by both BIMAS (explicit
number = 100) and by SYFPEITHI (score ≥10.0) [9,10]
were conducted, respectively, with the predictive epitopes
containing at least 10 amino acids. The same epitope
sequences predicted by both BIMAS and SYFPEITHI were
determined. The MHC II molecules predicted by
SYFPEITHI (score ≥10.0) with epitopes comprised of at
least 10 amino acids were done [10].
Epitopes in IEDB
The HA and NA gene sequences of sH1N1 viruses
isolated between 1998 and 2008 and pH1N1 viruses
isolated in 2009 were aligned by Clustal-W of MEGA 5.05
[11]. The amino acid sequences were analyzed and theconserved ratios were calculated. The previously experi-
mentally identified epitopes of HA and NA proteins in
sH1N1 proteins in IEDB were selected [12].
Validation of conversed epitopes
The predictive epitope sequences of pH1N1 genes were
compared with the corresponding genes of sH1N1 and
those with < 90% of conserved regions were rejected. The
remaining predictive epitope sequences of the pH1N1
genes were compared with epitopes in the IEDB with only
those epitopes of sH1N1 genes with conserved regions
of > 90% being selected. Finally, the only epitopes
with > 95% conserved in IEDB of sH1N1 genes as well as
the predictive epitope of pH1N1 was selected.
Homology Modeling
The homology model was generated using the SWISS-
MODEL homology-modeling server [13] and decorated
using the Cimera [14]. Some epitope regions were labeled
in the three- dimensional (3D) structure.
Results
Prediction of B-cell epitopes, MHC I Epitopes and MHC II
Epitopes
The HA and NA proteins of A/Guangdong/801/2009
(pH1N1) contained 567 amino acids coded by 1701 nucleo-
tides and 470 amino acids coded by 1410 nucleotides,
respectively; each having the identical gene lengths of the
sH1N1 virus. The HA and NA proteins of 68 pH1N1
viruses were aligned to illustrated the variations in the
proteins.
The B-cell epitopes predicted by ABCpred with a thresh-
old values of 0.51 were 330 in HA and 278 in NA. The
MHC I molecules in HLA-A1, HLA-A0201, HLA-A3 and
HLA-A1101 of HA and NA proteins predicted by BIMAS
(number of top-scoring = 100) were 400 in HA and 400 in
NA, meanwhile those in HLA-A*01, HLA-A*0201, HLA-
A*03 and HLA-A*1101 predicted by SYFPEITHI were
400 in HA and 400 in NA. The MHC II molecules in
HLA-DRB1*0101, HLA-DRB1*0301, HLA-DRB1* 0401
HLA- DRB1*0701, HLA-DRB1*1101, and HLA-DRB1
*1501 of HA and NA proteins predicted by SYFPEITHI
were 1423 in HA and 1146 in NA.
Gene alignment and IEDB epitope
The 1432 (95.8% of 1495) proteins of sH1N1 HA and
the 1928 (96.2% of 2005) proteins of sH1N1 NA were
aligned after the reduplications in downloaded se-
quences were discharged. According to the above pre-
dictive B-cell epitope, MHC I molecules and MHC II
molecules of pH1N1, the conserved ratio of each
sH1N1 epitope sequence was acquired. Forty-six epi-
tope sequences of sH1N1 HA proteins were searched in
IEDB (291 epitopes of sH1N1 HA in IEDB) for those
Table 1 Conservancy of hemagglutinin (HA) epitopes of sH1N1 and pH1N1 influenza viruses
HA sequence epitopea Number (%) of study
years conservedb
Epitope id in IEDB Possible B-cell epitopec Possible MHC I allelesd Possible MHC II allelese
IGYHANNSTDTVDTVLEK 99.9 95458 IGYHANNSTD(22–31) A*01,A*1101 DRB1*0101,DRB1*0301,DRB1*0401,
(22–39) NSTDTVDTVL(28–37) DRB1*0701, DRB1*1501
HANNSTDTVDTVLEKNV 99.9 128846 NSTDTVDTVL(28–37) A*01,A*1101 DRB1*0101,DRB1*0301,DRB1*0401,
(25–41)
STDTVDTVLEKNVTVTHS 99.9 95880 STDTVDTVLEKNVTVTHS A*01,A*0201, DRB1*0101,DRB1*0301,DRB1*0401,
(29–46) (29–46) A*03,A*1101 DRB1*0701, DRB1*1101,DRB1*1501
DTVDTVLEKNVTVTHSV 99.8 128470 NSTDTVDTVL(28–37) A*01,A*0201, DRB1*0101,DRB1*0301,DRB1*0401,
(31–47) DTVLEKNVTVTH(34–45) A*03,A*1101 DRB1*0701, DRB1*1101,DRB1*1501
DYEELREQLSSVSSFER 99.8 128481 YEELREQLSSVSSF A*01,A*0201 DRB1*0101,DRB1*0301,DRB1*0401,
(114–130) (115–128) A*03,A*1101 DRB1*0701, DRB1*1101,DRB1*1501
EQLSSVSSFERFE 99.8 113375 * A*0201,A*03, DRB1*0701
EQLSSVSSFERFEIFPK 99.9 128569 QLSSVSSFERFEIF A*0201,A*03, DRB1*0101,DRB1*0301,DRB1*0401,
(120–136) (121–134) A*1101 DRB1*0701, DRB1*1101,DRB1*1501
IQSRGLFGAIAGFIEGG 99.9 128979 SRGLFGAIAG A*0201,A*03, DRB1*0101,DRB1*0301,DRB1*0401,
(341–357) (343–352) A*1101 DRB1*0701,DRB1*1501
FGAIAGFIEGGWTGMVD 99.2 128623 AIAGFIEGGW A*1101 DRB1*0101,DRB1*0301,DRB1*0401,
(347–363) (349–358) DRB1*0701
FIEGGWTGMVDGWYGYH 99.2 128629 EGGWTGMVDGWY(355–366) A*1101 DRB1*0101,DRB1*0401,DRB1*0701,
(353–369) EGGWTGMVDGWYGY(355–368) DRB1*1501
TGMVDGWYGYHHQNEQG 99.2 130077 TGMVDGWYGYHH(359–370) A*1101 DRB1*0101,DRB1*0301,DRB1*0401,
(359–375) DRB1*0701,DRB1*1101,DRB1*1501
TGMVDGWYGYHHQNEQGS 99.2 95905 TGMVDGWYGYHH(359–370) A*1101 DRB1*0101,DRB1*0301,DRB1*0401,
(359–376) DRB1*0701,DRB1*1101,DRB1*1501
WYGYHHQNEQGSGYAAD 100.0 130354 YGYHHQNEQGSGYA A*1101 DRB1*0101,DRB1*0401,DRB1*0701,
(365–381) (366–379) DRB1*1101
TNKVNSVIEKMNTQFTA 99.6 130108 TNKVNSVIEKMNTQFTAV A*0201,A*1101 DRB1*0101,DRB1*0301,DRB1*0401,
(393–409) (393–410) DRB1*0701,DRB1*1101,DRB1*1501
NKVNSVIEKMNTQFTAVG 99.6 95623 * A*1101 DRB1*0101,DRB1*0301,DRB1*0401,
(394–411) DRB1*0701,DRB1*1101,DRB1*1501
SVIEKMNTQFTAV(398–410) 99.5 80042 * A*0201,A*1101 DRB1*0101,DRB1*0401,DRB1*1501
SVIEKMNTQFTAVGKE(398–413) 99. 127161



















Table 1 Conservancy of hemagglutinin (HA) epitopes of sH1N1 and pH1N1 influenza viruses (Continued)
EKMNTQFTAVGKE(401–413) 99.9 7980 * A*0201,A*03, A*1101 DRB1*0101,DRB1*0401,DRB1*1501
NLNKKVDDGFLDIWTYN 97.4 129494 * A*01,A*0201, DRB1*0101,DRB1*0301,DRB1*0401,
(423–439) A*03,A*1101 DRB1*0701,DRB1*1501
DDGFLDIWTYNAELLVL 97.5 128403 DDGFLDIWTYNAEL(429–442) A*01,A*0201, DRB1*0101,DRB1*0301,DRB1*0401
(429–445) A*03,A*1101 DRB1*0701,DRB1*1101,DRB1*1501
DGFLDIWTYNAELLV 97.1 113324 * A*1101 DRB1*0101,DRB1*0301,DRB1*0401
(430–444) DRB1*0701,DRB1*1101,DRB1*1501
IWTYNAELLVLLENERT 99.7 129015 WTYNAELLVLLENE(436–449) A*01,A*0201, DRB1*0101,DRB1*0301,DRB1*0401
(435–451) A*03,A*1101 DRB1*0701,DRB1*1101,DRB1*1501
WTYNAELLVLLENERTLD 100.0 96007 WTYNAELLVLLENE(436–449) A*01,A*0201, DRB1*0101,DRB1*0301,DRB1*0401
(436–453) A*03,A*1101 DRB1*0701,DRB1*1101,DRB1*1501
ELLVLLENERTLD 99.9 79809 * A*0201,A*1101 DRB1*0101,DRB1*0301,DRB1*0401,
(441–453) DRB1*0701,DRB1*1501
LKNNAKEIGNGCFEFYH 99.9 129255 KNNAKEIGNGCFEF(471–484) A*01,A*03, DRB1*0101,DRB1*0301,DRB1*0401,
(470–486) A*1101 DRB1*0701
MESVKNGTYDYPKYSEE 99.8 129388 * A*01,A*0201, DRB1*0101,DRB1*0301,DRB1*0701,
(493–509) A*03,A*1101 DRB1*1101,DRB1*1501
SLGAISFWMCSNGSLQ 99.7 129938 * A*0201,A*03, DRB1*0301,DRB1*0401, DRB1*1101,
(546–561) A*1101 DRB1*1501
SFWMCSNGSLQCRICI 99.3 129890 * A*1101 DRB1*0101,DRB1*0301,DRB1*0401,
(551–566) DRB1*0701,DRB1*1501
a. Epitopes in IEDB were experimentally identified epitopes in sH1N1 HA genes. b. The conservancy ratio of 1432 genes of sH1N1 HA sequences, whose strains isolated from 1968 to 2008. c. The B-cell epitopes of
pH1N1 HA genes are predicted by ABCpred in 10 mer or more, respectively. d. MHC I alleles of 10 mer and more of pH1N1 HA genes are Predicted by BIMAS (explicit number = 100) and SYFPEITHI (score ≥10.0),


















Table 2 Conservancy of neuraminidase (NA) epitopes of sH1N1 and pH1N1 influenza viruses
NA sequence epitopea Number (%) of study years conservedb Epitope id in IEDB Possible B-cell epitopec Possible MHC I allelesd Possible MHC II allelese
KDNSIRIGSKGDVFVIR 99.8 129048 SIRIGSKGDV(105–114) A*0201,A*03, DRB1*0101,DRB1*0301,DRB1*0401
(102–118) DNSIRIGSKGDVFV(103–116) A*1101 DRB1*0701,DRB1*1101,DRB1*1501
IGSKGDVFVIREPFIS 99.8 128924 GDVFVIREPF(112–121) A*0201,A*03, A*1101 DRB1*1101,DRB1*1501,
RTFFLTQGALLNDKHSN 99.5 127810 FLTQGALLND(133–142) A*01,A*03, DRB1*0101,DRB1*0301,DRB1*0401
(130–146) FFLTQGALLNDKHS(132–145) A*1101 DRB1*0701,DRB1*1101,DRB1*1501
ISGPDNGAVAVLKYNGI 99.5 128994 ISGPDNGAVAVLKY(195–208) A*01,A*0201 DRB1*0301,DRB1*0401,DRB1*1501
(195–211) GPDNGAVAVL(197–206)
VCRDNWHGSNRPWVSFN 99.9 130190 CRDNWHGSNRPW(292–303) A*01 DRB1*0101,DRB1*0401,DRB1*0701,
(291–307) RDNWHGSNRPWVSF(293–306) DRB1*1101
WSGYSGSFVQHPELTGL 99.9 130342 * A*0201,A*03, DRB1*0101,DRB1*0401,DRB1*0701,
(399–415) A*1101 DRB1*1101,DRB1*1501,
SFVQHPELTGLDCIRP 99.2 129889 * A*01, A*0201, DRB1*0101,DRB1*0401,DRB1*1501
(405–420) A*03, A*1101
PELTGLDCIRPCFWVEL 99.3 129560 * A*01,A*0201, DRB1*0101,DRB1*0301,DRB1*0401
(410–426) A*03,A*1101 DRB1*0701,DRB1*1101,DRB1*1501
a. Epitopes in IEDB were experimentally identified epitopes in sH1N1 NA genes. b. The conservancy ratio of 1928 genes of sH1N1 NA sequences, whose strains isolated from 1968 to 2008. c. The B-cell epitopes of
pH1N1 NA genes are predicted by ABCpred, respectively. d. MHC I alleles of 10 mer and more of pH1N1 NA genes are Predicted by BIMAS (explicit number = 100) and SYFPEITHI (score ≥10.0), respectively. The same


















Figure 1 HA tetramer decorated with two epitope regions. a. Side view; b. Vertical view. AA22-47 and AA341-363 are
IGYHANNSTDTVDTVLEKNVTVTHSV in red and IQSRGLFGAIAGFIEGGWTGMVD in magenta.
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one epitope sequences of NA proteins were done (80
epitopes of sH1N1 NA in IEDB). The epitopes
downloaded in IEDB mixed both B-cell epitopes and T-
cell epitopes.Figure 2 NA tetramer decorated with two epitope regions. AA102-123
RTFFLTQGALLNDKHSN in magenta.Conserved epitope
There were twenty-nine conserved epitope sequences in
HA proteins with 97.1%-100% of conserved ratios between
sH1N1 and pH1N1. Epitope SVIEKMNTQFTAV (IEDB
No.80042, aa398-410) was overlapped with epitopeand AA 130–146 are KDNSIRIGSKGDVFVIREPFIS in red and
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shown in Table 1. There were eight conserved epitope
sequences in NA proteins with conserved ratios of 99.3-
99.9% between sH1N1 and pH1N1, shown in Table 2.
Only 62.1% (18/29) of predictive B-cell epitopes of
pH1N1 HA proteins overlapped the conserved epitope
sequences in sH1N1 HA proteins. The predictive se-
quences of MHC I molecules and MHC II molecules of
pH1N1 covered almost all the conserved epitope se-
quences in sH1N1 HA proteins, but the positive ratios
in HLA-A*0101, A*0201, A*03 and A*1101 were 37.9%
(11/29), 62.1% (18/29), 48.3% (14/29) and 100% (29/29),
respectively. Only 37.5% (3/8) of predictive B-cell epi-
topes of pH1N1 NA proteins overlapped the conserved
epitope sequences in sH1N1 NA proteins. The predictive
sequences of MHC I molecules and MHC II molecules
of pH1N1 covered almost all the conserved epitope
sequences in sH1N1 NA proteins, but the positive ratios
in HLA-A*01, A*0201, A*03 and A*1101 were 62.5%
(5/8), 75.0% (6/8), 50.0% (4/8) and 75.0% (6/8),
respectively.
The predictive epitopes of MHC I and MHC II mole-
cules of pH1N1 covered almost all the conserved epi-
tope sequences in sH1N1 HA proteins, with the positive
ratios in HLA-DRB1*0101, DRB1*0301, DRB1*0401,
DRB1*0701, DRB1*1101 and DRB1*1501 being 86.2%
(25/29), 79.3% (23/29), 93.1% (27/29), 82.8% (24/29),
55.2% (16/29) and 82.8% (24/29), respectively; and those
in six HLA-DRB1 alleles were 75.0% (6/8), 50.0% (4/8),
87.5% (7/8), 62.5% (5/8), 75.0% (6/8) and 87.5% (7/8),
respectively.
3D structure
The H1 hemagglutinin trimer of strain A/801/2009 was
obtained using SWISS-MODEL. The 64.2% identity of
2wr0B in the Protein Data Bank (PDB) spanned amino
acid residues from 18 to 511 with 2.45 Å X-ray reso-
lution. The epitope region aa22-47 of the pH1N1 HA
protein referred to that of the sH1N1 HA protein in
IEDB (No. 95458, 95880, 128470 and 128846) and the
epitope region aa341-363 referred to that of the sH1N1
HA protein in IEDB (No.128623 and 128979), whose
atoms/bonds structures are shown in Figure 1, and were
positively predicted by all three methods (the B-cell
epitope ABCpred, the MHC I molecule BIMAS and
SYFPEITHI and the MHC II molecule SYFPEITHI. Both
epitope regions were neighboring in close proximity in
three-dimensional structure although the sequence posi-
tions spanned 294 amino acids, as shown in Figure 1.
The N1 neuraminidase tetramer of strain A/Guangdong/
801/2009 was obtained using SWISS- MODEL. The model
3ti4B in the Protein Data Bank (PDB) had the highest
sequence homology (99.5% identity) at amino acid residues
from 82 to 468 with 1.60 Å X-ray resolution, as shown inFigure 2. There were the epitope region aa102-123 of
pH1N1 HA proteins referred to that of sH1N1 HA pro-
teins in IEDB (No.128924 and 129048) and the epitope
region aa130-146 of pH1N1 HA proteins referred to that
of sH1N1 HA proteins in IEDB (No.127810), whose
atoms/bonds structures were shown in Figure 2, and were
positively predicted by the three methods. Both epitope
regions were close in three-dimensional structure and the
sequence positions spanned seven amino acids.
Discussion
The antigenic epitope analysis performed in this study
suggested the presence of pre-existing cross-reactive
humoral immunity, CD4+ and CD8+ T cellular immu-
nity to pH1N1 in the human population from the con-
served regions of HA and NA proteins. Although the
sH1N1 virus emerged since the 1918 pandemic, it con-
tinues to circulate among the human population today,
and might be the basis of pre-existing cross-reactive im-
munity [7,15,16]. However, such pre-existing T cell im-
mune responses do not prevent infection once a person
has been exposed to a virus [17], although T cell immunity
could contribute to the viral clearance of infected cells
(target cells), resulting in a reduction in disease severity,
and furthermore, may indirectly reduce person-to-person
spread [15,18].
Twenty-nine epitope regions of HA genes and eight
epitope regions of NA genes which had been experimen-
tally identified in sH1N1 viruses, were highly conserved
(97.1-100.0%) in the corresponding genes and predictive
epitopes of the pH1N1 viruses. Due to focus on the con-
served epitope sequences in this study, the properties of
IEDB epitopes (MHC binding, cellular assay, etc.) were
excluded. Immune antigens of pathogens mainly involve
the B-cell antigen, in addition to MHC I and MHC II
molecules. In all conserved epitopes (37/37) in this
study, more than half (23/37) of epitopes were B-cell
epitopes. Some antigens responded to produce specific
antibodies against the antigens. The MHC II molecules
were related to CD4+ cell, which involved the antigenic
recognition and presentation, were more active than the
MHC I molecules related to CD8+ cell in this study.
As common antigens of influenza existed, it is poten-
tially possible for a universal influenza vaccine to be
achieved within pathogen genomes based on epitopes
[19]. However, epitope selection to design a universal in-
fluenza vaccine warrants further research, particularly
for the existence of specific B-cell and T-cell epitope
repertoires, and also epitope binding to different MHC
alleles in the heterogeneous human population. Im-
munoinformatics is accelerating the development of
vaccines comprised of epitope ensembles and the con-
firmation of these vaccines in human clinical trials will
serve to usher in a new era of epitope driven vaccine
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ing two HA epitope regions and two NA epitope regions
in this study) are adjacent in the three-dimensional
structure, which suggests the importance of the combin-
ation of epitopes when designing vaccine. In summary,
these well-characterized epitopes could be combined as
potential vaccine candidates and may confer broader cell
mediated immunological responses to various subtypes
of influenza A viruses. The results in this study sug-
gested that highly conserved antigenic epitope regions
might act as the basis of common antigenic vaccines
against pH1N1 and sH1N1 viruses.
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